Literature DB >> 33817436

Experimental research in rats on the reactivity of new corneal blood vessels to adrenaline.

Bianca Damian Daniela1, Mihai Ghiță Aurelian2, Istrate Sânziana3, Cristina Coman Ioana3.   

Abstract

Aim: The purpose of this experimental study was to evaluate the existence of adrenergic receptors in ketamine-induced corneal blood vessels in rat pups.
Methods: The study of corneal neovascularization motricity was performed on 45-day-old Wistar rats in which, starting from the 15th day of life, corneal blood vessels were obtained by injecting intraperitoneal ketamine at a dose of 150 mg/ kg body weight, a total of 5 successive doses. The examination of the neovascularization was done with the help of a Nikon stereomicroscope connected to a video camera and a computer, the total magnification being 400X. The reactivity of the new corneal blood vessels to the administration in conjunctival instillations of a 1.5 mmol/L adrenaline solution was tested. The parameters followed were represented by variations in the caliber of corneal blood vessels. The data were analyzed using Microsoft Office Excel.
Results: Administration of distilled water did not produce statistically significant changes in corneal blood vessels, while adrenaline produced a statistically significant constriction of vascular diameter (p=0.01 at T9, p=0.004 at T10, p=0.019 at time T11 of examinations). Conclusions: The results showed that adrenaline produces vasoconstriction in the new corneal blood vessels, which allows us to assume that they contain α-adrenergic receptors. However, we cannot say that corneal pathological vessels do not contain β2-type adrenergic receptors, because the effect of adrenaline may be an algebraic sum between vasoconstriction produced by stimulating α-adrenergic receptors and vasodilation produced by stimulating β2-adrenergic receptors, but in which the vasodilating effect may be masked by the vasoconstrictor effect given by a higher density of α-adrenergic receptors. Abbreviations: A= adrenaline, DNM = non-measurable diameter, NA= noradrenaline, Std.Er.= Standard error. ©Romanian Society of Ophthalmology.

Entities:  

Keywords:  adrenaline; cornea; new blood vessels; vasoconstriction

Year:  2021        PMID: 33817436      PMCID: PMC7995500          DOI: 10.22336/rjo.2021.12

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  43 in total

1.  LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.

Authors:  S N Louis; T L Nero; D Iakovidis; G P Jackman; W J Louis
Journal:  Eur J Pharmacol       Date:  1999-02-19       Impact factor: 4.432

Review 2.  Advances in the design and synthesis of prazosin derivatives over the last ten years.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Expert Opin Ther Targets       Date:  2011-12-13       Impact factor: 6.902

3.  Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.

Authors:  C Hoffmann; M R Leitz; S Oberdorf-Maass; M J Lohse; K-N Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-17       Impact factor: 3.000

4.  Cultured human trabecular meshwork cells express functional alpha 2A adrenergic receptors.

Authors:  W D Stamer; Y Huang; R E Seftor; S S Svensson; R W Snyder; J W Regan
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-11       Impact factor: 4.799

Review 5.  alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling.

Authors:  R M Graham; D M Perez; J Hwa; M T Piascik
Journal:  Circ Res       Date:  1996-05       Impact factor: 17.367

6.  Differences between presynaptic and postsynaptic alpha-adrenoceptors in the isolated nictitating membrane of the cat: effects of metanephrine and tolazoline.

Authors:  S Arbilla; S Z Langer
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

7.  Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles.

Authors:  D Y Yu; E N Su; S J Cringle; V A Alder; P K Yu; L Desantis
Journal:  Exp Eye Res       Date:  1998-07       Impact factor: 3.467

8.  Alpha 1-adrenoceptors in the corneal endothelium.

Authors:  R J Walkenbach; G S Ye; P S Reinach; F Boney
Journal:  Exp Eye Res       Date:  1992-09       Impact factor: 3.467

Review 9.  Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects.

Authors:  N Svedmyr
Journal:  Pharmacotherapy       Date:  1985 May-Jun       Impact factor: 4.705

Review 10.  Everything You Always Wanted to Know about β3-AR * (* But Were Afraid to Ask).

Authors:  Giorgia Schena; Michael J Caplan
Journal:  Cells       Date:  2019-04-16       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.